Member Info for Hawker

Gilt and UK corporate yields are back at their July levels which should give some relief for the pension deficit of Carclo, among others. Would be useful to see what 10bps in Gilt yields does for their deficit, let's see if that gets coverage in the upcoming update. I suspect the recent move could mean the recent cancelled dividend may yet sit in their bank account in lieu of potentially being paid into the pension, or not if yields continue higher and thus a return to divi payments may come sooner than analysts are expecting.

Looks like another good volume day for Carclo today, let's see who's shares are changing hands this time.

http://www.edisoninvestmentresearch.com/research/report/carclo3 Carclo's recent H1 trading update is encouraging, except for the frustrating news that VW is delaying its flagship Phaeton vehicle, which will now be launched as an all-electric vehicle. The short-term impact on our forecasts is not immaterial but the share price reaction appears overdone. In our initiation note we identified Carclo’s earnings multiples discount against its UK comparators with established growth stories. We think the extent of the discount is unjustified and see the long-term story remaining firmly intact, but accept that, although the delay is not of Carclo’s making, it may now take a bit longer to close the gap. PT 175p

talks ended, no surprise there then !

Can anyone tell me what's priced into this situation, the shares have been 21p pretty much all year, long before talk of the strategic review, so seems the shares are pricing very low probability of any value being generated here, what am I missing ?

last divi was paid in 2010, roughly 15p when the shares were around 230p so a yield of 6.5%. I read recently that some analysts are expecting a return to divi payments this coming year with a yield of 5%, if true that should help the shares get back to the 220-230p level.

I think this is what you may have been after, not sure why this didn't make it to RNS. http://www.ekfdiagnostics.com/news.aspx?id=170 In addition to creating the new roles bringing structure and discipline in product development governance as the company continues to grow, EKF has also restructured its organization into the three aforementioned divisions of the IVD sector. These are further segmented into key markets; for example, the Point-of-Care division is made up of: Hematology; Diabetes Care; and Maternal and Women’s Health. Each of these business units are overseen by an experienced director. For example, holding over 20 years’ experience in international medical technology companies, Karin Dahllof has recently joined EKF from CellaVision as EKF’s Business Unit Director for Hematology.

This is encouraging, good spot Rivaldo, I don't think they were on the share register before so this could be their first move into the shares.

Just think what the stock would do if there was an actual buyer around, it's a tiny market cap really (less than 0.8x sales), especially when you put Ruffer's share sale in context to the size of their funds, 9mln shares x 116p, a mere £10.5m for 13% of this company, this smacks of towel throwing, shame really. Does anyone know how long Ruffer was involved or how much they paid for their shares ?

Having watched several large holders reduce their holdings over the past year (Blackrock, L&G and I think JPM) it begs the question who has bought as I don't recall seeing any RNS announcements regarding this, odd given the sizes have been sufficiently large.

Ruffer cuts further to below 2% (see second RNS) and yet no announcement as to who has acquired the shares With any luck this will mark the end of the heavy selling pressure that has dogged this stock for the past two years.

No real surprise here but Blackrock are the next fund manager to give Chris Malley and Carclo a vote of no confidence by selling their holding of 3mln plus shares to zero, no wonder this stock is unable to go up or rise above its 50 day moving average. There's been no positive holding disclosures so no clue as to who has acquired these shares as yet. The newly appointed broker have a hard task with this once exciting story it seems, perhaps time for a management re-shuffle ?

I see sell-side volumes have been picking up again in this stock, no surprise perhaps given the news has been negative for nearly two years now, wonder if any more of the big asset managers are bailing or if this is just private investors finally capitulating ? When are the results, perhaps they'll kitchen-sink in an attempt to put a line under the stock price ? And to think this stock was 285p in January vs 85p today, -70% ytd, ouch !

Good stuff Lindon, do those numbers include the $10mln pre-payment they received from Atmel do you know ?

And to think they had a 500p PT not too long ago, this stock is -80% from the highs and -66% this year, is it an AIM stock in disguise ?

Well said Lindon. I haven't looked at this company in a while but am not surprised by this announcement, although as you say it really could have come out much earlier as they would now be presenting a solution rather than another period of uncertainty. I will say though that Atmel appear to have let the company down and Carclo should be applying pressure on them to compensate for poor execution. Atmel would do well to buy out Carclo and I wonder if this has been their strategy all along by dragging their feet in order to acquire the IP for next to nothing. Good riddance to CIT !

Saw this and started dreaming about Atmel/Samsung working together in harmony, lol ! http://www.businessinsider.com/samsung-note-edge-2014-9

Directors buying here is a small positive, would like to see a major investor building a position from the recent selling interest or perhaps one of the existing shareholders upping their positions, no sign of this yet.

Legal & General, according to the RNS it looks as though they'e disposed of their complete holding of 4.94 million shares. I wouldn't rush in yet as it's quite likely the selling broker is sitting on a rump as they may well have bid for the last piece to get the job done. Didn't L&G sell some earlier this year, 400 thousand or so ? If so, they've been selling since then, not surprising given the daily volume but the meltdown is as much to do with this sell order as anything. I would be a buyer if it turns out a significant player has taken the other side, else it's just the small holders who have absorbed this stock, let's wait and see.

There's little surprise in the FY numbers of note, analysts were expecting EPS of 6p and Sales of £97.13m so a flat/positive outcome in the shares today should be seen as a positive. We need to see material announcements from the Atmel/Carlco partnership before anyone will consider returning this stock to the "growth" segment, can't see that happening anytime soon given the competition in the MM/ITO arena, this is one for the back burner.